Obsession Poised to Surpass Major Box Office Milestones This Weekend Indias Net Foreign Direct Investment Rises in FY26 on Higher Gross Inflows Portfolio Flows Weaken Nio Shares Surge on Launch of First Flagship SUV in Over Two Years Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting Baby Retailer with Bed Bath Beyond Spanish Brewer Hijos de Rivera Establishes Italian Subsidiary to Bolster European Presence Bond Market Anxiety Overstated Economist Argues for New Central Banking Model to Empower Progressive Policy APWC Q3 1997 Earnings Profit Misses Estimates Amid Regional Economic Challenges FTFT Q2 2024 Earnings Narrowing Losses Amidst Strategic Transformation in Blockchain and Fintech CXW Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower Edgewell Personal Care Company EPC Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges Stock Edges Higher Magna International MGA Q1 2026 Earnings Strong EPS Beat Drives Stock Higher UBFO Q4 2025 Earnings Solid EPS of 019 Reported Shares Remain Flat AMETEK Inc AME Rallies 216 as Price Approaches Key Resistance Near 241 Banco Bradesco BBD Edges Higher in Quiet Trading Testing Key Levels Innovative Eyewear LUCY Edges Higher as Shares Test Key Resistance Near 107 Graham Corporation GHM Holds Near Support as Slight Decline Tests Key Levels CorVel Corp CRVL Slips 27 as Stock Tests Key Support Zone Microsofts New Trusted Tech Lead Faces Tension Between Speed and Responsibility in AI Development CLF Q1 2026 Earnings Earnings Miss Expectations Amid Challenging Steel Market Cousins Properties CUZ Sees Modest Uptick as Office REIT Holds Support Levels Hilton Grand Vacations HGV Slips 114 as Stock Tests Key Support Levels Sanara MedTech SMTI Gains 175 as Stock Tests Key Resistance Level KLA Corporation KLAC Retreats from Resistance Testing Key Support Levels Rigetti Computing RGTI Faces Selling Pressure as Share Price Declines 6 Reborn Coffee REBN Edges Lower as Stock Consolidates Near Key Support Level Xenon Pharmaceuticals XENE Edges Higher Amidst Neutral Trading Sonoma Pharmaceuticals SNOA Edges Higher Testing Key Resistance at 113